GSK3772701 900 mg

DRUG2 trials

Sponsors

GlaxoSmithKline, GlaxoSmithKline Research And Development Limited

Conditions

MalariaMalaria, Falciparum

Phase 2

A Phase 2A study of a novel antimalarial pyrrolidinamide in adult patients with uncomplicated P. falciparum malaria

Active, not recruitingPACTR202508592564689

GlaxoSmithKline Research And Development LimitedMalaria

Start: 2026-02-03Target: 70Updated: 2026-09-14

A Phase 2A Study of a Novel Antimalarial Pyrrolidinamide in Adult Patients With Uncomplicated P. Falciparum Malaria

Not yet recruitingNCT07545681

GlaxoSmithKlineMalaria, Falciparum

Start: 2026-07-28End: 2027-07-29Target: 70Updated: 2026-07-08